Evaluation of the Multidimensional Dyspnea Profile (MDP)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-19

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of this multicenter prospective cohort study is the evaluation of the multidimensional qualities of dyspnea in a number of diseases using the Multidimensional Dyspnea Profile (Banzett et al, ERJ 2015).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02827721

COPD Obstructive Ventilation Disorder Pulmonary Emphysema

UNKNOWN

Morphine for Dyspnea in Pulmonary Fibrosis

NCT04497831

Idiopathic Pulmonary Fibrosis (IPF)

UNKNOWN PHASE3

Diaphragmatic Function as a Biomarker

NCT05903001

Dyspnea; Asthmatic COPD Fibrosis +3 more

RECRUITING

The Application of Impulse Oscillometry on the Diagnosis of ACOS,Asthma and COPD.

NCT03181152

Asthma-COPD Overlap Syndrome Asthma COPD +1 more

RECRUITING

Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD

NCT03287921

COPD

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study sites will examine patients with COPD (Chronic obstructive pulmonary disease) in state of acute exacerbation and in stable state, patients with congestive heart failure (CHF) in state of acute decompensated cardiac insufficiency, and patients newly diagnosed with obstructive sleep apnea (OSA) as a control group.

In the acute setting of COPD and CHF, the questionnaire will be given at the day of hospital admission and at the day of discharge. The patients will additionally fill the Severe Respiratory Insufficiency (SRI) Questionnaire (in COPD) or the Physical Activity Questionnaire 50+ (in CHF).

In stable state of COPD, the questionnaires will be given once during a routine control visit at the hospital or the medical practice.

In OSA, the questionnaire will be given once during the first visit in the sleep laboratory.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Exacerbation CHF OSA COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

multicenter prospective cohort study

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COPD Exacerbation

the questionnaire MDP will be administered at the day of hospital admission and at the day of discharge.

Group Type ACTIVE_COMPARATOR